Insmed (INSM) Enterprise Value (2010 - 2026)
Insmed (INSM) recorded Enterprise Value of $22.11 billion in Q2 2026, up 14.0% from $19.39 billion a year earlier but down 35.3% from the prior quarter.
Powered by 
Analysis
Insmed (INSM) Enterprise Value (2010 - 2026) Analysis & Trends
On a TTM basis, Insmed's Enterprise Value came in at $17.78 billion as of Jun 30, 2026, up 16.3% year-over-year; for FY2025, it was $35.86 billion, up 227.5% from FY2024.
- Annual Enterprise Value has increased for three straight years, with a five-year compound annual growth rate of 65.5% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $10.95 billion in FY2024 (+187.8%), $3.81 billion in FY2023 (+143.6%), $1.56 billion in FY2022 (-38.0%) and $2.52 billion in FY2021 (-12.8%).
- Quarterly Enterprise Value has ranged from $1.33 billion in Q1 2023 to $35.86 billion in Q4 2025 over the past five years.
- On a year-over-year basis, Enterprise Value has increased for 13 consecutive quarters, with growth averaging 177.9% over the last eight quarters.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 373.7% in Q2 2024, against a decline of 38.8% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $34.18 billion (Q1 2026), $35.86 billion (Q4 2025) and $28.93 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Insmed | 25.69 Bn | 20.19 Bn | 358.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.11 Bn |
| Mar 31, 2026 | 34.18 Bn |
| Dec 31, 2025 | 35.86 Bn |
| Sep 30, 2025 | 28.93 Bn |
| Jun 30, 2025 | 19.39 Bn |
| Mar 31, 2025 | 12.68 Bn |
| Dec 31, 2024 | 10.95 Bn |
| Sep 30, 2024 | 11.59 Bn |
| Jun 30, 2024 | 9.92 Bn |
| Mar 31, 2024 | 3.43 Bn |
| Dec 31, 2023 | 3.81 Bn |
| Sep 30, 2023 | 2.83 Bn |
| Jun 30, 2023 | 2.09 Bn |
| Mar 31, 2023 | 1.33 Bn |
| Dec 31, 2022 | 1.56 Bn |
| Sep 30, 2022 | 2.11 Bn |
| Jun 30, 2022 | 1.81 Bn |
| Mar 31, 2022 | 2.17 Bn |
| Dec 31, 2021 | 2.52 Bn |
| Sep 30, 2021 | 2.41 Bn |
API Access
Insmed Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();